We used a humanized PD-1/PD-L1 knock-in MC38 tumor model, considering its potential as an immunogenic cancer model and in combination with programmed death-1/programmed death ligand 1 (PD-1/PD-L1) immune checkpoint blockade. This evidence concerns the gene PDCD1 and neoplasm.